What's in ALCON LABS INC's pipeline?

ALCON LABS INC has 5 drugs in our index: 5 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with ALCON LABS INC's portfolio?

Top competitors by shared drug class: APOGEPHA Arzneimittel GmbH.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/alcon-labs-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

ALCON LABS INC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ALCON LABS INC pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Tryptyr	ACOLTREMON	marketed	TRPM8 Thermoreceptor Agonist [EPC]		Ophthalmology	2025-01-01
Rhopressa	NETARSUDIL	marketed	Rho Kinase Inhibitor	rho kinase	Cardiovascular	2017-01-01
Cyclogyl	CYCLOPENTOLATE	marketed	cyclopentolate	Muscarinic acetylcholine receptor M3	Ophthalmology	1974-01-01
Enlon-Plus	Atropin	marketed	Non-Standardized Insect Allergenic Extract [EPC]	Muscarinic acetylcholine receptor M3	Ophthalmology	1960-01-01
Enlon-Plus	Atropine Sulfate	marketed	Antimuscarinic agent	Muscarinic acetylcholine receptors	Other	1960-01-01

Therapeutic area mix

Ophthalmology · 3
Cardiovascular · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

APOGEPHA Arzneimittel GmbH · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for ALCON LABS INC:

Cite this brief

Drug Landscape (2026). ALCON LABS INC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alcon-labs-inc. Accessed 2026-06-10.